{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:20:36Z","timestamp":1794554436901,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030692","name":"National Institute on Drug Abuse Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"VA Biomedical Laboratory Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA028504"],"award-info":[{"award-number":["R01AA028504"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P50AA030407\\u20135131"],"award-info":[{"award-number":["P50AA030407\\u20135131"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA026723"],"award-info":[{"award-number":["R01AA026723"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA020735"],"award-info":[{"award-number":["R01AA020735"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P20GM103427"],"award-info":[{"award-number":["P20GM103427"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P30CA036727"],"award-info":[{"award-number":["P30CA036727"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2025.118924","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:57:51Z","timestamp":1768251471000},"page":"118924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Characterizing ghrelin\u2019s role in dysregulating GLP-1-mediated function and promoting the development of alcohol-associated liver disease"],"prefix":"10.1016","volume":"195","author":[{"given":"Sundararajan","family":"Mahalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Bellamkonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum K.","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4486-1052","authenticated-orcid":false,"given":"Ojeshvi","family":"Ethiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagasundaram","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittibabu","family":"Guda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah B.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Rasineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","article-title":"Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease","volume":"23","author":"Axley","year":"2019","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118924_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cld.806","article-title":"Epidemiology of alcohol use and alcoholic liver disease","volume":"13","author":"Mellinger","year":"2019","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"4","key":"10.1016\/j.biopha.2025.118924_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100104","article-title":"Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease","volume":"2","author":"Gao","year":"2024","journal-title":"eGastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118924_bib4","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00334.2018","article-title":"Chronic alcohol exposure alters circulating insulin and ghrelin levels: role of ghrelin in hepatic steatosis","volume":"316","author":"Rasineni","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2025.118924_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Muller","year":"2019","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"Muller","year":"2015","journal-title":"Mol. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2025.118924_bib8","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/acer.14967","article-title":"Role of the ghrelin system in alcohol use disorder and alcohol-associated liver disease: a narrative review","volume":"46","author":"Kharbanda","year":"2022","journal-title":"Alcohol Clin. Exp. Res"},{"key":"10.1016\/j.biopha.2025.118924_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146562","article-title":"Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1","volume":"1727","author":"Jerlhag","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2025.118924_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.physbeh.2019.02.008","article-title":"Ghrelin: from a gut hormone to a potential therapeutic target for alcohol use disorder","volume":"204","author":"Farokhnia","year":"2019","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s42003-024-06303-5","article-title":"Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet","volume":"7","author":"Leko","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2025.118924_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118924_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psyneuen.2018.07.021","article-title":"Alcohol consumption is positively associated with fasting serum ghrelin in non-dependent adults: results from the population-based LIFE-adult-study","volume":"97","author":"Wittekind","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.cmet.2019.04.012","article-title":"Targeting peripheral CB1 receptors reduces ethanol intake via a gut-brain axis","volume":"29","author":"Godlewski","year":"2019","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.biopha.2025.118924_bib15","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.2337\/diabetes.53.12.3142","article-title":"Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents","volume":"53","author":"Dezaki","year":"2004","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2025.118924_bib16","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2337\/db07-0345","article-title":"Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin","volume":"56","author":"Dezaki","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118924_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109059","article-title":"Ghrelin regulates adipose tissue metabolism: Role in hepatic steatosis","volume":"322","author":"Rasineni","year":"2020","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2025.118924_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115613","article-title":"Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease","volume":"213","author":"Mahalingam","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118924_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116595","article-title":"Role of ghrelin hormone in the development of alcohol-associated liver disease","volume":"174","author":"Mahalingam","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118924_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/hep4.1322","article-title":"Serum metabolomic profiling identifies key metabolic signatures associated with pathogenesis of alcoholic liver disease in humans","volume":"3","author":"Yang","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2025.118924_bib21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fphar.2018.01168","article-title":"GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Pharm."},{"issue":"Pt B","key":"10.1016\/j.biopha.2025.118924_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2018.01.013","article-title":"GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence","volume":"136","author":"Jerlhag","year":"2018","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118924_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188314","article-title":"Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake","volume":"135","author":"Farokhnia","year":"2025","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118924_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107312","article-title":"IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target","volume":"207","author":"Bruns Vi","year":"2024","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118924_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2025.118924_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0898-6568(03)00128-1","article-title":"Dimerization of G-protein-coupled receptors: roles in signal transduction","volume":"16","author":"Bai","year":"2004","journal-title":"Cell Signal"},{"issue":"26","key":"10.1016\/j.biopha.2025.118924_bib27","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/jm010290+","article-title":"Dimerization of G-protein-coupled receptors","volume":"44","author":"Dean","year":"2001","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118924_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106809","article-title":"Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules","volume":"140","author":"Qian","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118924_bib29","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00143.2019","article-title":"Reply to \"Letter to Editor: chronic alcohol exposure alters circulating insulin and ghrelin levels in hepatic steatosis: a translational research perspective\"","volume":"317","author":"Rasineni","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2025.118924_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fendo.2011.00002","article-title":"Biological significance of GPCR heteromerization in the neuro-endocrine system","volume":"2","author":"Kamal","year":"2011","journal-title":"Front Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118924_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tips.2010.08.003","article-title":"Class A GPCR heterodimers: evidence from binding studies","volume":"31","author":"Birdsall","year":"2010","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118924_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2013.00148","article-title":"Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward","volume":"7","author":"Schellekens","year":"2013","journal-title":"Front Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118924_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/cn500318q","article-title":"Ghrelin's orexigenic effect is modulated via a serotonin 2C receptor interaction","volume":"6","author":"Schellekens","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118924_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fnmol.2018.00245","article-title":"Ghrelin through GHSR1a and OX1R heterodimers reveals a galphas-cAMP-cAMP response element binding protein signaling pathway in vitro","volume":"11","author":"Xue","year":"2018","journal-title":"Front Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118924_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00221-013-3622-1","article-title":"Functional significance of serotonin receptor dimerization","volume":"230","author":"Herrick-Davis","year":"2013","journal-title":"Exp. Brain Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1074\/jbc.M112.382473","article-title":"Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling","volume":"288","author":"Schellekens","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118924_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1013","article-title":"Differential effects of glucose-dependent insulinotropic polypeptide receptor\/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells","volume":"10","author":"Al-Zaid","year":"2022","journal-title":"Pharm. Res Perspect."},{"issue":"45","key":"10.1016\/j.biopha.2025.118924_bib38","doi-asserted-by":"crossref","first-page":"18607","DOI":"10.1073\/pnas.1205227109","article-title":"Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery","volume":"109","author":"Harikumar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118924_bib39","first-page":"197","article-title":"Liquid diet technique of ethanol administration: 1989 update","volume":"24","author":"Lieber","year":"1989","journal-title":"Alcohol. Alcohol."},{"key":"10.1016\/j.biopha.2025.118924_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12876-016-0433-4","article-title":"Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology","volume":"16","author":"Rasineni","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118924_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41366-018-0013-5","article-title":"Development and initial characterization of a novel ghrelin receptor CRISPR\/Cas9 knockout wistar rat model","volume":"43","author":"Zallar","year":"2019","journal-title":"Int J. Obes. (Lond. )"},{"key":"10.1016\/j.biopha.2025.118924_bib42","article-title":"Ghrelin receptor deletion reduces binge-like alcohol drinking in rats","author":"Zallar","year":"2018","journal-title":"J. Neuroendocr."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118924_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2007.07.007","article-title":"Systemic ghrelin sensitizes cocaine-induced hyperlocomotion in rats","volume":"146","author":"Wellman","year":"2008","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.biopha.2025.118924_bib44","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/en.2015-1732","article-title":"High-fat diet and palmitate alter the rhythmic secretion of glucagon-like peptide-1 by the rodent L-cell","volume":"157","author":"Gil-Lozano","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biocel.2005.07.010","article-title":"Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity","volume":"38","author":"Donohue","year":"2006","journal-title":"Int. J. Biochem Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"GH. A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib47","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/S0021-9258(18)61564-9","article-title":"Chronic ethanol administration impairs the binding and endocytosis of asialo-orosomucoid in isolated hepatocytes","volume":"262","author":"Casey","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib48","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41401-021-00758-6","article-title":"Signaling profiles in HEK 293T cells co-expressing GLP-1 and GIP receptors","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2025.118924_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-62703-426-5_7","article-title":"A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer","volume":"1013","author":"Kufareva","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"D1","key":"10.1016\/j.biopha.2025.118924_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118924_bib51","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.23569","article-title":"Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway","volume":"51","author":"Gupta","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2025.118924_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1567095","article-title":"Liraglutide attenuates nonalcoholic fatty liver disease through adjusting lipid metabolism via SHP1\/AMPK signaling pathway","volume":"2019","author":"Yu","year":"2019","journal-title":"Int J. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib53","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.3390\/cimb45060288","article-title":"The role of GLP1-RAs in direct modulation of lipid metabolism in hepatic tissue as determined using in vitro models of NAFLD","volume":"45","author":"Petrovic","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118924_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2010.03793.x","article-title":"Dysregulation of plasma ghrelin in alcoholic cirrhosis","volume":"73","author":"Goodyear","year":"2010","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"5","key":"10.1016\/j.biopha.2025.118924_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13211","article-title":"The glucagon-like peptide-1 system is modulated by acute and chronic alcohol exposure: findings from human laboratory experiments and a post-mortem brain study","volume":"27","author":"Farokhnia","year":"2022","journal-title":"Addict. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118924_bib56","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1530-0277.2007.00452.x","article-title":"Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines","volume":"31","author":"Kang","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"10","key":"10.1016\/j.biopha.2025.118924_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100517","article-title":"Inhibition of ghrelin activity by receptor antagonist [d-Lys-3] GHRP-6 attenuates alcohol-induced hepatic steatosis by regulating hepatic lipid metabolism","volume":"9","author":"Rasineni","year":"2019","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ijnp\/pyab004","article-title":"Neuroendocrine response to exogenous ghrelin administration, combined with alcohol, in heavy-drinking individuals: findings from a randomized, double-blind, placebo-controlled human laboratory study","volume":"24","author":"Farokhnia","year":"2021","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118924_bib59","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2002.35954","article-title":"The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats","volume":"123","author":"Date","year":"2002","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.biopha.2025.118924_bib60","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1210\/en.2003-0143","article-title":"Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells","volume":"144","author":"Anini","year":"2003","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.biopha.2025.118924_bib61","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/endo.143.6.8840","article-title":"Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats","volume":"143","author":"Anini","year":"2002","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib62","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae160","article-title":"Selective Colocalization of GHSR and GLP-1R in a Subset of Hypothalamic Neurons and Their Functional Interaction","volume":"166","author":"Aguggia","year":"2024","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41421-024-00649-0","article-title":"Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with G(s) proteins","volume":"10","author":"Cong","year":"2024","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41467-021-27760-0","article-title":"Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation","volume":"13","author":"Deganutti","year":"2022","journal-title":"Nat. Commun."},{"issue":"7694","key":"10.1016\/j.biopha.2025.118924_bib65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature25773","article-title":"Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex","volume":"555","author":"Liang","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2025.118924_bib66","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/JOE-21-0206","article-title":"The emerging role of heterodimerisation and interacting proteins in ghrelin receptor function","volume":"252","author":"Price","year":"2021","journal-title":"J. Endocrinol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.120037","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:00:00Z","timestamp":1794441600000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:39:17Z","timestamp":1778693957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":66,"alternative-id":["S0753332225011187"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118924","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing ghrelin\u2019s role in dysregulating GLP-1-mediated function and promoting the development of alcohol-associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118924"}}